Study for Patients with Diabetic Neuropathy or Neuropathic Back Pain

What we are studying

The purpose of this research study is to test whether Donepezil (used for treatment of Alzheimer’s disease) will have any effect (good or bad) on your current pain. Donepezil is an FDA approved drug. Donepezil is considered to be investigational in this study. What we learn in this study may lead to future research studies to try to find effective combinations of medicine therapy for pain management. In this study Donepezil will be compared to placebo (placebo contains no active medication).

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 80

Eligibility Criteria

  • Diagnosed with diabetic neuropathy or subjects that have had back surgery and continue to have chronic lower back pain

What is involved

  • Study involvement lasts 10 weeks and includes 4 study visits

Compensation

Participants will receive $150.00 for completing all scheduled study visits.

Contact Information

Study Coordinator
Regina Curry
Email
recurry@wakehealth.edu
Phone
336-716-4294

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.